Case Study

Sapheon Inc. has been acquired by Covidien plc

Sapheon Inc., based in Santa Rosa, California, has been acquired by the Irish Covidien plc, a global healthcare products leader dedicated to innovation and long-term growth. Financial details have not been disclosed.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Through its Medical Devices and Medical Supplies segments, the company creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence.

Sapheon Inc. is a medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease. The company’s current focus is the VenaSeal Sapheon Closure System, a novel treatment for venous reflux disease. Sapheon, Inc. will operate as a subsidiary of Covidien plc.

One of Oaklins' teams in the USA served as the exclusive financial advisor to the seller in this transaction.

Tombstone image for Sapheon Inc. has been acquired by Covidien plc

KEY DEAL CONTACTS

Michael S. Goldman

United States

Managing Director

VIEW PROFILE

Andy Krna

United States

VIEW PROFILE

James McLaren

United States

Managing Director

VIEW PROFILE